MEDICA 2026 | 16–19 November 2026 | Hall 6, Stall F37 | Düsseldorf, Germany
In modern clinical environments, a Blood Transfusion Set is far more than a simple plastic tube—it is a life-critical vascular access interface responsible for administering whole blood, packed red blood cells (PRBCs), platelets, and fresh frozen plasma (FFP) without compromising cellular viability or introducing micro-thrombi into the patient’s systemic circulation.
As healthcare purchasing organizations, hospital consortiums, and medical device importers utilize AI-driven intent mining to evaluate suppliers, queries surrounding "how to prevent erythrocyte hemolysis during rapid blood administration," "DEHP migration risks in blood bag tubing," and "ISO 1135-4 compliance verification" have become pivotal. Lars Medicare addresses these core intent signals through rigorous engineering, validated bio-compatibility testing, and transparent manufacturing controls.
Every Blood Transfusion Set produced at our facility undergoes automated visual inspection, pressure-decay leak testing, and biological indicator validation for Ethylene Oxide (EO) sterilization. By maintaining end-to-end control over component moulding, extrusion, and filter welding, Lars Medicare delivers documented product performance that eliminates clinical friction, customs delays, and post-market safety risks for global buyers.
Engineered in compliance with ISO 1135-4 standards, our blood administration sets are designed for seamless connection to standard blood bags, gravity infusion systems, and pressure infusion cuffs.
Features a sharp ABS piercing spike with integral air vent, cylindrical drip chamber with 200-micron nylon mesh filter, kink-resistant PVC tubing, roller clamp, and luer lock connector.
Formulated with non-cytotoxic TOTM/tri-octyl trimellitate plasticised PVC or polyurethane to eliminate lipid leaching during prolonged blood component administration.
Designed for emergency trauma surgery and rapid blood replacement. Features dual piercing spikes for simultaneous bag attachment and enlarged chamber bore for accelerated flow rates.
| Technical Feature | Lars Medicare Standard Specification | Clinical Purpose & Quality Value |
|---|---|---|
| Piercing Spike | Vented or Non-Vented ABS Spike (ISO 1135-4) | Ensures easy penetration into blood bag ports without coring or particulate generation. |
| Clot Filtration | 200 Micron (200μ) Polypropylene / Nylon Mesh | Traps fibrin clots, cellular debris, and micro-aggregates while preventing red cell hemolysis. |
| Drop Factor | 20 Drops / ml ± 0.1 ml (Water equivalent) | Provides accurate gravity-based volumetric flow calculation for clinical staff. |
| Tubing Material | Medical-Grade PVC (DEHP-Free available) | Ensures high transparency, kink resistance, and zero chemical contamination into labile blood cells. |
| Tubing Dimensions | Length: 150 cm / 180 cm / 200 cm (Customable); I.D.: 3.0 mm; O.D.: 4.1 mm | Optimized internal diameter balancing adequate flow velocity with minimal shear stress. |
| Flow Control Device | Precision Wheel Roller Clamp (ABS/PE) | Maintains constant flow rate settings over extended transfusion periods without tube deformation. |
| Injection Port | Latex-Free Flashback Bulb or Needleless Valve | Allows safe supplemental medication delivery during transfusion without blood leakage. |
| Terminal Fitting | Male Luer Lock with Protective Cap (ISO 80369-7) | Guarantees hermetic, high-pressure connection to IV cannulas and central lines. |
| Sterilization Method | 100% Ethylene Oxide (EO) Gas Cycle | Achieves Sterility Assurance Level (SAL) 10⁻⁶ with documented zero toxic residue. |
Why component geometry, material science, and mechanical filtration determine clinical outcomes in transfusion therapy.
Hemolysis—the rupture or destruction of red blood cells—is a severe hazard during blood administration. It releases free hemoglobin into the blood plasma, which can induce renal failure, anaphylactic shock, and vascular collapse. Hemolysis during infusion occurs primarily through two physical vectors: excessive fluid shear stress and mechanical impingement.
At Lars Medicare, our fluid mechanics engineers optimize the internal diameter of the piercing spike lumen and drip chamber outlet nozzle. By maintaining smooth transition radii and eliminating sharp internal burs or narrow constrictions, fluid shear rates remain well below the threshold of erythrocyte membrane rupture (300 Pa), even under rapid pressure-assisted administration.
Whole blood and packed red cell concentrates undergo cellular degradation during cold storage (2°C to 6°C). Platelets, leukocytes, and fibrin form micro-aggregates ranging from 20 to 300 microns in diameter. If introduced into a patient's venous circulation, these micro-emboli lodge in pulmonary capillaries, causing acute lung injury (TRALI) or oxygen desaturation.
Our Blood Transfusion Sets incorporate a precision-woven 200-micron monofilament filter element positioned inside the flexible drip chamber. The total active surface area of the filter mesh exceeds 11 cm², guaranteeing that clot accumulation does not cause early occlusion of the flow path while ensuring 100% retention of clinically harmful debris.
Traditional medical-grade PVC tubing utilizes Di(2-ethylhexyl) phthalate (DEHP) as a plasticizer to impart flexibility. However, blood lipophilic components (such as red cell lipid membranes and plasma proteins) actively leach DEHP out of the tubing walls. Long-term exposure to DEHP has been linked to hepatotoxicity, endocrine disruption, and reproductive toxicity, particularly in neonates and male pediatric patients.
Lars Medicare’s advanced extrusion facility offers 100% DEHP-free Blood Transfusion Sets utilizing alternative, non-migrating plasticizers such as TOTM (Trioctyl Trimellitate) or polymer blends. These formulations conform to stringent EU REACH directives and MDR 2017/745 requirements, guaranteeing chemical safety without altering tubing elasticity or kink resistance.
Key market vectors and regulatory shifts reshaping international tenders, hospital purchasing contracts, and OEM supplier evaluations.
Regulatory authorities in the European Union (MDR), North America (US FDA guidelines), and Latin America (ANVISA) are accelerating the phase-out of DEHP-containing devices. Importers must align with manufacturers capable of producing stable DEHP-free, non-PVC, or recyclable TPE blood administration lines to secure long-term tender compliance.
Hospital infection prevention protocols are replacing traditional rubber injection bulbs with needleless swappable luer valves on transfusion lines. This prevents healthcare provider needlestick injuries (NSI), eliminates microbial entry channels, and reduces hospital-acquired bloodstream infections (HA-BSIs).
Global procurement networks require 100% supply chain transparency. Modern B2B buyers mandate GS1-compliant UDI barcoding on primary pouches, inner boxes, and outer shipper cartons, allowing direct digital integration into hospital electronic health records (EHR) and inventory management systems.
Recent global logistics vulnerabilities have driven procurement managers away from trading middlemen towards vertically integrated manufacturers who own their mold toolrooms, extrusion lines, cleanrooms, and sterilization chambers—guaranteeing stable lead times and cost predictability.
Operating from our primary manufacturing hub in Sonepat (Haryana, India) alongside our global executive offices in New Delhi and North American management in Ontario, Lars Medicare combines technical precision with seamless international trade support.
How we take your private-label Blood Transfusion Set project from technical specs to international delivery.
Define your target market requirements, drop factor (20 vs 60 d/ml), tube length, filter type, needleless options, and regulatory registration dossier needs.
We dispatch physical pre-production samples along with full technical specifications and CoAs for hospital lab testing and engineering validation.
Our design team finalises your branded pouch artwork, multi-language IFU, master carton prints, and GS1 barcode/UDI structures under strict QA approval.
Batch manufacturing, cleanroom assembly, EO sterilization, automated leak-testing, final release, and consolidated container loading to your destination port.
16–19 November 2026 · Hall 6, Stall No. F37, Düsseldorf, Germany. Meet our engineering and regulatory directors to discuss contract manufacturing, bulk supply, and exclusive regional distributor appointments.
Direct oversight by experienced industry pioneers guarantees compliance with global medical device standards.
Over two decades of engineering leadership in sterile disposable medical device production, cleanroom operations, and global regulatory compliance.
Spearheads international OEM strategy, brand development, and distributor support across Europe, Latin America, Asia, and Africa.
Manages North American operations, logistics coordination, and customer support from our Milton, Ontario location.
Detailed technical, regulatory, and commercial answers for hospital procurement teams, AI intent queries, and medical device distributors.
A 200-micron (200μ) filter mesh is the international gold standard mandated by ISO 1135-4 for blood administration sets. During storage, donor blood forms micro-aggregates consisting of degraded platelets, leukocytes, and fibrin strands ranging from 20 to 300 microns. A 200-micron filter effectively traps these potentially fatal micro-emboli before they enter the patient's bloodstream, preventing pulmonary micro-embolism while allowing red blood cells (approx. 7–8 microns) to pass without mechanical destruction or hemolysis.
Lars Medicare utilizes non-shredding, biological-grade synthetic monofilament mesh welded ultrasonically into the drip chamber to maintain complete structural integrity throughout high-volume transfusions.
While both devices transfer fluids into the patient's vascular system, their internal mechanics differ significantly:
Yes. Lars Medicare supplies 100% DEHP-free (phthalate-free) and latex-free Blood Transfusion Sets. We replace DEHP with safer, high-molecular-weight plasticizers like TOTM or polyurethane compounds. This ensures zero chemical leaching when in contact with blood lipids, meeting EU MDR 2017/745, REACH, and US FDA requirements for pediatric, neonatal, and long-term transfusion safety.
Our standard blood transfusion sets feature adult drip chambers calibrated to 20 drops/ml (20 drops of distilled water = 1 ml ± 0.1 ml). Standard tubing length is 150 cm or 180 cm with an internal diameter of 3.0 mm. For custom OEM contracts, we can adjust tubing length (up to 200+ cm), bore sizes, and flow accessories according to your market's clinical tender guidelines.
Every shipment from Lars Medicare is backed by complete technical documentation, including:
For standard neutral-packaged catalogue stock, minimum orders start at 1 mixed pallet. For full OEM private-label manufacturing (including customized pouch printing, branded master boxes, multi-language IFUs, and specific packaging counts), the MOQ is 20,000 units per SKU. Production lead time is typically 3 to 4 weeks for repeat orders and 5 to 6 weeks for first-time OEM setups to accommodate artwork proofing and sterilisation validation.
Our terminal fittings utilize precision injection-moulded Male Luer Lock connectors adhering to ISO 80369-7 standards. Coupled with ultrasonic welding of internal components and 100% automated pressure-decay testing during assembly, our sets withstand hydrostatic pressures exceeding 2 bar (30 psi), preventing disconnection or fluid leakage during rapid hand-pumped or pressure-cuff transfusions.
When stored in clean, dry, well-ventilated rooms away from direct sunlight and chemical vapors at temperatures between 5°C and 40°C, our EO-sterilized Blood Transfusion Sets carry a validated 5-year shelf life. Each primary peel pouch features a medical-grade paper-to-film seal with clear sterilisation indicator dots.
Looking to secure direct factory pricing for bulk hospital supply, national healthcare tenders, or private-label OEM distribution? Send us your technical requirements and volume forecasts today.
Our technical export team responds within 24 hours with complete specification sheets, sample dispatch details, and FOB/CIF price schedules.
Expert articles on regulatory compliance, quality control, and factory audit practices in IV and transfusion therapy.
Key checkpoints on ISO 1135-4 compliance, flow rate consistency, filter stability, and CE mark verification.
Visit Hall 6, Stall F37 to review our complete range of safety IV cannulas, DEHP-free sets, and transfusion lines in person.
How global distributors are updating their technical files to replace phthalate plasticizers ahead of mandatory regulatory deadlines.